Non-steroidal anti-inflammatory drugs inhibit bone healing: A review

Veterinary and Comparative Orthopaedics and Traumatology

Volumn 23, Issue 6, 2010, Pages 385-392

  Barry, S ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Bone healing; Non steroidal anti inflammatory drugs; Nsaid

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL; ANIMAL DISEASE; BONE DISEASE; DOG; DOSE RESPONSE; DRUG EFFECT; FRACTURE; HUMAN; METHODOLOGY; MOUSE; RABBIT; RAT; REVIEW; SPINE FUSION; WOUND HEALING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BONE DISEASES; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; FRACTURES, BONE; HUMANS; MICE; RABBITS; RATS; SPINAL FUSION; WOUND HEALING;

ANIMALIA; CANIS FAMILIARIS; EQUIDAE; MUS; ORYCTOLAGUS CUNICULUS; RATTUS;

EID: 78649878768     PISSN: 09320814     EISSN: None     Source Type: Journal    
DOI: 10.3415/VCOT-10-01-0017     Document Type: Review

References (67)

1. Ro J, Sudmann E, Marton PF. Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 1976; 47: 588-599.
2. Sudmann E, Hagen T. [Indomethacin-induced delayed fracture healing]. Arch Orthop Unfall-Chir 1976; 85: 151-154.
3. O'Connor JP, Lysz T. Celecoxib, NSAIDs and the skeleton. Drugs Today 2008; 44: 693-709.
4. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971; 231: 232-235.
5. Clark TP. The clinical pharmacology of cyclooxygenase-2-selective and dual inhibitors. Vet Clin Small Anim 2006; 36: 1061-1085.
6. Dekel S, Lenthall G, Francis MJO. Release of prostaglandins from bone and muscle after tibial fracture. J Bone Joint Surg 1981; 63-B: 185-189.
7. Simon AM, O'Connor JP. Dose and time-dependent effects of cyclooxygenase-2 inhibition on fracture- healing. J Bone Joint Surg Am 2007; 89: 500-511.
8. Gerstenfeld LC, Al-Ghawas M, Alkhiary YM, et al. Selective and nonselective cyclooxygenase-2 inhibitors and experimental fracture-healing. Reversibility of effects after short-term treatment. J Bone Joint Surg Am 2007; 89: 114-125.
9. Blackwell KA, Raisz LG, Pilbeam CC. Prostaglandins in bone: bad cop, good cop? Trends Endocrinol Metab 2010; 21: 294-301.
10. McKibben B. The biology of fracture healing in long bones. J Bone Joint Surg Br 1978; 60-B: 150-162.
11. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998; 355S: S7-S21.
12. Frost HM. The regional acceleratory phenomenon: A review. Henry Ford Hosp Med J 1983; 31: 3-9.
13. Einhorn TA. The science of fracture healing. J Orthop Traum 2005; 19(10 Suppl): S4-S6.
14. Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor ßsuperfamily during murine fracture healing. J Bone Miner Res 2002; 17: 513-520.
15. Tsiridis E, Upadhyay N, Giannoudis P. Molecular aspects of fracture healing: Which are the important molecules? Injury 2007; 38(S1): S11-S25.
16. Al-Aql ZS, Alagl AS, Graves DT, et al. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 2008; 87: 107-118.
17. Shih MS, Norridin RW. Effects of prostaglandins on regional remodeling changes during tibial healing in beagles: a histomorphometric study. Calcif Tissue Int 1986; 39: 191-197.
18. Shih MS, Norridin RW. Effects of prostaglandin E2 on rib fracture healing in beagles: histomorphometric study on periosteum adjacent to the fracture site. Am J Vet Res 1986; 47: 1561-1564.
19. Paralkar VM, Borovecki F, Cameron KO, et al. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc Natl Acad Sci USA 2003; 100: 6736-6740.
20. Tanaka M, Sakai A, Uchida S, et al. Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats. Bone 2004; 34: 940-948.
21. Zhang X, Schwarz EM, Young DA, et al. Cyclooxygenase- 2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J Clin Invest 2002; 109: 1405-1415.
22. Kellinsalmi M, Parikka V, Risteli J, et al. Inhibition of cyclooxygenase-2 down-regulates osteoclast and osteoblast differentiation and favours adipocyte formation in vitro. Eur J Pharmacol 2007; 572: 102-110.
23. Krischak GD, Augat P, Blakytny R, et al. The nonsteroidal anti-inflammatory drug diclofenac reduces appearance of osteoblasts in bone defect healing in rats. Arch Orthop Trauma Surg 2007; 127: 453-458.
24. Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004; 200: 400-406.
25. Chikazu D, Li X, Kawaguchi H, et al. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfa1 binding site: Role in effects of bone morphogenetic protein 2 in vitro and in vivo. J Bone Miner Res 2002; 17: 1430-1440
26. Spiro AS, Beil FT, Baranowsky A, et al. BMP-7-induced ectopic bone formation and fracture healing is impaired by systemic NSAID application in C57BL/6-mice. J Orthop Res 2010; 28: 785-791.
27. Sahin M, Sahin E, Gümüslü S. Cyclooxygenase-2 in cancer and angiogenesis. Angiology 2009; 60: 242-253.
28. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001; 29: 560-564.
29. Murnaghan M, Li G, Marsh DR. Nonsteroidal anti-inflammatory drug-induced fracture nonunion: An inhibition of angiogenesis? J Bone Joint Surg Am 2006; 88: 140-147.
30. Keller J, Kjærsgaard-Andersen P, Bayer-Kristensen I, et al. Indomethacin and bone trauma. Effects on remodeling of rabbit bone. Acta Orthop Scand 1990; 61: 66-69.
31. Reikeraas O, Engebretsen L. Effects of ketorolac tromethamine and indomethacin on primary and secondary bone healing. An experimental study in rats. Arch Orthop Trauma Surg 1998; 118: 50-52.
32. Long J, Lewis S, Kuklo T, et al. The effect of cyclooxygenase-2 inhibitors on spinal fusion. J Bone Joint Surg Am 2002; 84-A: 1763-1768.
33. Nyangoga H, Aguado E, Goyenvalle E, et al. A nonsteroidal anti-inflammatory drug (ketoprofen) does not delay β-TCP bone graft healing. Acta Biomater 2010; 6: 3310-3317.
34. Gerstenfeld LC, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003; 21: 670-675.
35. Simon AM, Manigrasso MB, O'Connor JP. Cyclooxygenase 2 function is essential for bone fracture healing. J Bone Miner Res 2002; 17: 963-976.
36. Brown KM, Saunders MM, Kirsch T, et al. Effect of COX-2-specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg 2004; 86: 116-123.
37. Endo K, Sairyo K, Komatsubara S, et al. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthop 2005; 76: 470-474.
38. Beck A, Krischak G, Sorg I, et al. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003; 123: 327-332.
39. Krischak G, Augat P, Sorg T, et al. Effects of diclofenac on periosteal callus maturation in osteotomy healing in an animal model. Arch Orthop Trauma Surg 2007; 127: 3-9.
40. Dimmen S, Nordsletten L, Engebretsen L, et al. Negative effect of parecoxib on bone mineral during fracture healing in rats. Acta Orthop 2008; 79: 438-444.
41. Goodman SB, Ma T, Mitsunaga L, et al. Temporal effects of a COX-2 selective NSAID on bone ingrowth. J Biomed Mater Res 2005; 72: 279-287.
42. Leonelli SM, Goldberg BA, Safanda J, et al. Effects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am J Orthop 2006; 35: 79-84.
43. Dimmen S, Nordsletten L, Madsen JE. Parecoxib and indomethacin delay early fracture healing: a study in rats. Clin Orthop Rel Res 2009; 467: 1992-1999.
44. Ochi H, Hara Y, Asou Y, et al. Effect of long-term administration of non-steroidal anti-inflammatory drugs on fracture healing in dogs. (Poster presentation) ACVS Veterinary Symposium 2009 October 8-10; Washington DC, USA.
45. Giordano V, Giordano M, Knackfuss IG, et al. Effect of tenoxicam on fracture healing in rat tibiae. Injury 2003; 34: 85-94.
46. Riew KD, Long J, Rhee J, et al. Time-dependent inhibitory effects of indomethacin on spinal fusion. J Bone Joint Surg Am 2003; 85: 632-634.
47. Allen HL, Wase A, Bear WT. Indomethacin and aspirin: effect of nonsteroidal anti-inflammatory agents on the rate of fracture repair in the rat. Acta Orthop Scand 1980; 51: 595-600.
48. Fransen M, Neal B. Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty. Cochrane Database Syst Rev 2004; 3: CD001160.
49. Almåsbakk K, Røysland P. Does indomethacin (IMC) prevent postoperative ectopic ossification in total hip replacement? (Abstract) Acta Orthop Scand 1977; 48: 556.
50. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of long bone nonunion. J Bone Joint Surg Br 2003; 85-B: 700-705.
51. Adolphson P, Abbaszadegan H, Jonsson U, et al. No effects of piroxicam on osteopenia and recovery after Colles' fracture. Arch Orthop Trauma Surg 1993; 112: 127-130.
52. Davis TRC, Ackroyd CE. Non-steroidal anti-inflammatory agents in the management of Colles' fractures. Br J Clin Pract 1988; 42: 184-189.
53. Bhattacharyya T, Levin R, Vrahas MS, et al. Nonsteroidal antiinflammatory drugs and nonunion of humeral shaft fractures. Arthritis Rheum 2005; 53: 364-367.
54. Rohde C, Anderson DE, Bertone AL, et al. Effects of phenylbutazone on bone activity and formation in horses. Am J Vet Res 2000; 61: 537-543.
55. Mbugua SW, Skoglund LA, Løkken P. Effects of phenylbutazone and indomethacin on the post-operative course following experimental orthopaedic surgery in dogs. Acta Vet Scand 1989; 30: 27-35.
56. Pountos I, Georgouli T, Blokhuis TJ, et.al. Pharmacological agents and impairment of fracture healing: What is the evidence? Injury 2008; 39: 384-394.
57. Sudmann E, Bang G. Indomethacin-induced inhibition of Haversian remodelling in rabbits. Acta Orthop Scand 1979; 50: 621-627.
58. Törnkvist H, Lindholm TS. Effect of ibuprofen on mass and composition of fracture callus and bone. Scand J Rheumatol 1980; 9: 167-171.
59. Elves MW, Bayley I, Roylance PJ. The effect of indomethacin upon experimental fractures in the rat. Acta Orthop Scand 1982; 53: 35-41.
60. Persson P, Sisask G, Nilsson O. Indomethacin inhibits bone formation in inductive allografts but not in autografts. Acta Orthop 2005; 76: 465-469.
61. O'Connor JP, Capo JT, Tan V, et al. A comparison of the effects of ibuprofen and rofecoxib on rabbit fibula osteotomy healing. Acta Orthop 2009; 80: 597-605.
62. Rueben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am 2005; 87: 536-542.
63. Deguchi M, Rapoff AJ, Zdeblick TA. Posterolateral fusion for isthmic spondylolisthesis in adults: Analysis of fusion rate and clinical results. J Spinal Disord 1998; 11: 459-464.
64. Glassman SD, Rose SM, Dimar JR. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 1998; 23: 834-838.
65. Giannoudis PV, MacDonald DA, Matthews SJ, et al. Nonunion of the femoral diaphysis: The influence of reaming and non-steroidal anti-inflammatory drugs. J Bone Joint Surg Br 2000; 82-B: 655-658.
66. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal anti-inflammatory drugs compromise spinal fusion. Can J Anesth 2005; 52: 506-512.
67. Pradhan BB, Tatsumi RL, Gallina J, et al. Ketorolac and spinal fusion: Does the perioperative use of ketorolac really inhibit spinal fusion? Spine 2008; 33: 2079-2082.